JD Supra

FDA rethinks need for comparative efficacy studies for certain biosimilars

The U.S. Food and Drug Administration (FDA) issued new draft guidance on October 29, 2025, proposing what it said were “major updates to ...
BioPharma Dive

FDA, aiming to lower drug costs, moves to speed approval of biosimilars

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...
JD Supra

Streamlining The Studies: New FDA Draft Guidance Aims To Speed Up Biosimilar Development

On Wednesday, the FDA issued a new draft guidance proposing to reduce the need for sponsors to conduct a comparative efficacy ...
Orthopedics This Week

Smith+Nephew comparative study1 shows PICO sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare cost…

Smith+Nephew announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure ...

Comparative Study: Microsoft And Industry Competitors In Software Industry

When closely examining Microsoft, the following trends emerge: The Price to Earnings ratio of 38.39 is 0.29x lower than the ...